MedPath

Effect of ventilation during complete anaesthesia on release of chemicals of lung infection /injury in patients survived from COVID-19

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2022/07/043797
Lead Sponsor
Department of Anaesthesiology Pain Medicine and Critical Care AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients more or equal to 18 years classified as American Society of Anaesthesiologists (ASA) physical status I/II/ III scheduled for elective or emergency extra thoracic surgery under general anaesthesia

2.Minimum 4 week interval between COVID-19 infection and the scheduled surgery

3.Pulmonary involvement during COVID -19 infection as evident by dyspnea or hypoxemia, chest Xray/CECT findings or oxygen requirement

Exclusion Criteria

1.Post COVID-19 without pulmonary symptoms/radiological involvement/oxygen requirement/undiagnosed COVID.

2.Patients with history or clinical signs of lung disease before COVID-19 infection

3.Patients on ongoing immunosuppression by drugs for underlying condition

4.Elevated leukocyte count or clinical signs of a systemic infection

5.Intra-thoracic surgery

6.ASA class IV

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To monitor proinflammatory cytokine responses as an estimate of lung inflammation/injury during mechanical ventilation in COVID-19 survivors who had pulmonary involvementTimepoint: baseline, at the end of surgery, 1 hour after the surgery
Secondary Outcome Measures
NameTimeMethod
.To determine incidence of post-operative pulmonary complications (POPC) in patients of general anesthesia with mechanical ventilation <br/ ><br>.To determine whether serum and bronchoalveolar lavage fluid (BALF) biomarkers are capable of identifying patients at risk of POPC <br/ ><br>.To determine the correlation between CT score of pulmonary involvement with the serum and BALF biomarkers of lung injury <br/ ><br>.To assess difference in length of hospital stay of the patients in both groups <br/ ><br>Timepoint: 7 days and 6 months
© Copyright 2025. All Rights Reserved by MedPath